These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9825768)

  • 41. ETA receptor-mediated Ca2+ mobilisation in H9c2 cardiac cells.
    Ceccarelli F; Scavuzzo MC; Giusti L; Bigini G; Costa B; Carnicelli V; Zucchi R; Lucacchini A; Mazzoni MR
    Biochem Pharmacol; 2003 Mar; 65(5):783-93. PubMed ID: 12628492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity.
    von Geldern TW; Tasker AS; Sorensen BK; Winn M; Szczepankiewicz BG; Dixon DB; Chiou WJ; Wang L; Wessale JL; Adler A; Marsh KC; Nguyen B; Opgenorth TJ
    J Med Chem; 1999 Sep; 42(18):3668-78. PubMed ID: 10479298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelin receptor antagonists.
    Nelson JB
    World J Urol; 2005 Feb; 23(1):19-27. PubMed ID: 15654644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist.
    Wu C; Chan MF; Stavros F; Raju B; Okun I; Mong S; Keller KM; Brock T; Kogan TP; Dixon RA
    J Med Chem; 1997 May; 40(11):1690-7. PubMed ID: 9171878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock.
    Wanecek M; Oldner A; Sundin P; Alving K; Weitzberg E; Rudehill A
    Eur J Pharmacol; 1999 Dec; 386(2-3):235-45. PubMed ID: 10618475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic endothelin exposure inhibits connexin43 expression in cultured cortical astroglia.
    Rozyczka J; Figiel M; Engele J
    J Neurosci Res; 2005 Feb; 79(3):303-9. PubMed ID: 15605384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding of a new bioactive 31-amino-acid endothelin-1 to an endothelin ET(B) or ET(B)-like receptor in porcine lungs.
    Kitamura H; Cui P; Sharmin S; Yano M; Kido H
    Eur J Pharmacol; 2003 Mar; 465(1-2):31-8. PubMed ID: 12650830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ca2+ signalling by endothelin receptors in rat and human cultured airway smooth muscle cells.
    Maxwell MJ; Goldie RG; Henry PJ
    Br J Pharmacol; 1998 Dec; 125(8):1768-78. PubMed ID: 9886769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro characterisation of Ro 46-8443, the first non-peptide antagonist selective for the endothelin ETB receptor.
    Breu V; Clozel M; Burri K; Hirth G; Neidhart W; Ramuz H
    FEBS Lett; 1996 Mar; 383(1-2):37-41. PubMed ID: 8612786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
    Nambi P; Pullen M; Kincaid J; Nuthulaganti P; Aiyar N; Brooks DP; Gellai M; Kumar C
    Mol Pharmacol; 1997 Oct; 52(4):582-9. PubMed ID: 9380020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional and binding characterization of endothelin receptors in human bronchus: evidence for a novel endothelin B receptor subtype?
    Hay DW; Luttmann MA; Pullen MA; Nambi P
    J Pharmacol Exp Ther; 1998 Feb; 284(2):669-77. PubMed ID: 9454813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
    Pollock DM; Allcock GH; Krishnan A; Dayton BD; Pollock JS
    Am J Physiol Renal Physiol; 2000 Feb; 278(2):F279-86. PubMed ID: 10662732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The endothelin/sarafotoxin-induced increase of the proliferation of undifferentiated and DMSO-differentiated GEM-81 goldfish erythrophoroma cells is mediated by ETB receptors.
    Filadelfi AM; Ramanzini GC; Visconti MA; Castrucci AM
    Pigment Cell Res; 2004 Oct; 17(5):480-7. PubMed ID: 15357834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.
    Bianciotti LG; de Bold AJ
    Cardiovasc Res; 2001 Mar; 49(4):808-16. PubMed ID: 11230980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death.
    Raschack M; Unger L; Riechers H; Klinge D
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S397-9. PubMed ID: 8587425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-activity relationships of a novel series of orally active nonpeptide ETA and ETA/B endothelin receptor-selective antagonists.
    Doherty AM; Patt WC; Repine J; Edmunds JJ; Berryman KA; Reisdorph BR; Walker DM; Haleen SJ; Keiser JA; Flynn MA
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S358-61. PubMed ID: 8587414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endothelin ETB receptor signaling in the median eminence and subfornical organ of the rat brain.
    Garrido Mdel R; Israel A
    Neuropeptides; 2004 Oct; 38(5):304-10. PubMed ID: 15464196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting endothelin receptor type A in human cervical carcinoma cells.
    Cirilli A; Simeone P; Muller A; Bagnato A; Venuti A
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S72-5. PubMed ID: 15838364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Endothelin---biosynthesis, function and role in cardiovascular diseases].
    Potaczek DP; Sanak M
    Pol Arch Med Wewn; 2002 Jul; 108(1):703-14. PubMed ID: 12412417
    [No Abstract]   [Full Text] [Related]  

  • 60. Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1.
    Pollock DM
    Physiol Genomics; 2001 Jun; 6(1):39-43. PubMed ID: 11395545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.